Mitochondrial-Derived Peptide MOTS-c Suppresses Ovarian Cancer Progression by Attenuating USP7-Mediated LARS1

Yadong Yin1, Yujie Li2, Boyi Ma1

  • 1Department of Gynaecology and Obstetrics, Xijing Hospital, Air Force Medical University, Xi'an, 710032, China.

Insights

Reduced levels of MOTS-c peptide in ovarian cancer (OC) correlate with poor prognosis. This study reveals MOTS-c peptide

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Mitochondrial-nuclear communication is crucial for cellular homeostasis.
  • Mitochondria-derived ORFan peptide (MOTS-c) is a potential retrograde mitochondrial signal.
  • The role of MOTS-c in cancer, particularly ovarian cancer (OC), remains largely uninvestigated.

Purpose of the Study:

  • To investigate the role of MOTS-c in ovarian cancer (OC) tumorigenesis.
  • To explore the therapeutic potential of MOTS-c in OC treatment.

Main Methods:

  • Quantification of MOTS-c levels in OC patient serum and tissues.
  • In vitro assays to assess the effects of exogenous MOTS-c on OC cell proliferation, migration, invasion, cell cycle, and apoptosis.
  • Mechanistic studies involving ubiquitination, proteasomal degradation, and protein-protein interactions (MOTS-c, LARS1, USP7).
  • In vivo anti-tumor efficacy and toxicity studies of MOTS-c in OC models.

Main Results:

  • MOTS-c levels are significantly reduced in OC patient serum and tumors, correlating with poor prognosis.
  • Exogenous MOTS-c inhibits OC cell proliferation, migration, and invasion, while inducing cell cycle arrest and apoptosis.
  • MOTS-c promotes LARS1 ubiquitination and proteasomal degradation by interfering with USP7-mediated deubiquitination.
  • LARS1 is upregulated and exhibits oncogenic functions in OC.
  • MOTS-c demonstrates significant anti-tumor effects in vivo without systemic toxicity.

Conclusions:

  • This study establishes a critical role for MOTS-c in ovarian cancer (OC).
  • Reduced MOTS-c levels are linked to poor OC prognosis.
  • MOTS-c exhibits potent anti-tumor activity against OC through LARS1 regulation.
  • MOTS-c presents a promising therapeutic target for ovarian cancer (OC) treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.1K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K